Literature DB >> 11486098

Incidence of the major stroke subtypes: initial findings from the North East Melbourne stroke incidence study (NEMESIS).

A G Thrift1, H M Dewey, R A Macdonell, J J McNeil, G A Donnan.   

Abstract

BACKGROUND AND
PURPOSE: Population-based stroke incidence studies are the only accurate way to determine the number of strokes that occur in a given society. Because the major stroke subtypes have different patterns of incidence and outcome, information on the natural history of stroke subtypes is essential. The purpose of the present study was to determine the incidence and case-fatality rate of the major stroke subtypes in a geographically defined region of Melbourne, Australia.
METHODS: All suspected strokes that occurred among 133 816 residents of suburbs north and east of Melbourne, Australia, during a 12-month period of 1996 and 1997 were identified and assessed. Multiple overlapping sources were used to ascertain cases, and standard criteria for stroke and case-fatality were used. Stroke subtypes were defined by CT, MRI, and autopsy.
RESULTS: Three hundred eighty-one strokes occurred among 353 persons during the study period, with 276 (72%) being first-ever-in-a-lifetime strokes. Of these, 72.5% (95% CI 67.2% to 77.7%) were cerebral infarction, 14.5% (95% CI 10.3% to 18.6%) were intracerebral hemorrhage, 4.3% (95% CI 1.9% to 6.8%) were subarachnoid hemorrhage, and 8.7% (95% CI 5.4% to 12.0%) were stroke of undetermined type. The 28-day case-fatality rate was 12% (95% CI 7% to 16%) for cerebral infarction, 45% (95% CI 30% to 60%) for intracerebral hemorrhage, 50% (95% CI 22% to 78%) for subarachnoid hemorrhage, and 38% (95% CI 18% to 57%) for stroke of undetermined type.
CONCLUSIONS: The overall distribution of stroke subtypes and 28-day case-fatality rates are not significantly different from those of most European countries or the United States. There may, however, be some differences in the incidence of subtypes within Australia.

Entities:  

Mesh:

Year:  2001        PMID: 11486098     DOI: 10.1161/01.str.32.8.1732

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  52 in total

Review 1.  Applicability and relevance of models that predict short term outcome after intracerebral haemorrhage.

Authors:  M J Ariesen; A Algra; H B van der Worp; G J E Rinkel
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-06       Impact factor: 10.154

2.  The impact of delays in computed tomography of the brain on the accuracy of diagnosis and subsequent management in patients with minor stroke.

Authors:  J M Wardlaw; S L Keir; M S Dennis
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-01       Impact factor: 10.154

3.  Exact location of sensorimotor cortex injury after photochemical modulation; evidence of stroke based on stereological and morphometric studies in mice.

Authors:  Maryam Shahi; Ali Abedelahi; Daryoush Mohammadnejad; Reza Rahbarghazi; Seyed Hossein Rasta; Mohammad Karimipour
Journal:  Lasers Med Sci       Date:  2020-04-15       Impact factor: 3.161

Review 4.  Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends.

Authors:  N K de Rooij; F H H Linn; J A van der Plas; A Algra; G J E Rinkel
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04-30       Impact factor: 10.154

5.  Predictors of 30-day mortality and 90-day functional recovery after primary intracerebral hemorrhage : hospital based multivariate analysis in 585 patients.

Authors:  Kyu-Hong Kim
Journal:  J Korean Neurosurg Soc       Date:  2009-06-30

6.  Poor outcome in primary intracerebral haemorrhage: results of a matched comparison.

Authors:  M Barber; G Roditi; D J Stott; P Langhorne
Journal:  Postgrad Med J       Date:  2004-02       Impact factor: 2.401

7.  The health loss from ischemic stroke and intracerebral hemorrhage: evidence from the North East Melbourne Stroke Incidence Study (NEMESIS).

Authors:  Dominique A Cadilhac; Helen M Dewey; Theo Vos; Rob Carter; Amanda G Thrift
Journal:  Health Qual Life Outcomes       Date:  2010-05-14       Impact factor: 3.186

8.  Effect of race/ethnicity on the efficacy of warfarin: potential implications for prevention of stroke in patients with atrial fibrillation.

Authors:  Albert Yuh-Jer Shen; Wansu Chen; Janis F Yao; Somjot S Brar; Xunzhang Wang; Alan S Go
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

9.  Lack of benefits for prevention of cardiovascular disease with aspirin therapy in type 2 diabetic patients--a longitudinal observational study.

Authors:  Wilson Y Leung; Wing-yee So; Derek Stewart; Augustine Lui; Peter C Tong; Gary T Ko; Alice P Kong; Ronald C Ma; Francis K Chan; Xilin Yang; Sau-chu Chiang; Juliana C Chan
Journal:  Cardiovasc Diabetol       Date:  2009-10-30       Impact factor: 9.951

10.  Smoking as a crucial independent determinant of stroke.

Authors:  Seana L Paul; Amanda G Thrift; Geoffrey A Donnan
Journal:  Tob Induc Dis       Date:  2004-06-15       Impact factor: 2.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.